At a weight reduction clinic giving hCG injections, 21% (60/287) of assessed attendees had evidence of acute hepatitis B infection.
In plain wordsAt a clinic giving hCG injections, 21% of assessed attendees had evidence of acute hepatitis B infection.
- Outcome
- Not applicableAcute hepatitis B in the clinic cohort
- Study
n = 287
- Outcome group
- Adverse events · Infection
Measurements
- Acute hepatitis B infection
- 60 persons
- assessed clinic attendees, of 287
- Acute hepatitis B infection
- 21%
- assessed clinic attendees
Source sentences
Of this cohort, 21% (60/287) had evidence of acute infection with hepatitis B virus (either documented clinical cases or antibody to hepatitis B core antigen, IgM positive).
2 context sentences(design, population, supporting numbers)
Clinical history, risk factor assessment, serologic evaluation, and review of clinic injection records were obtained on 287 (84%) of 341 persons who had attended clinic 1 in the first 6 months of 1985.
Before the onset of illness, each case-patient had received a series of injections of human chorionic gonadotropin administered by jet injectors at clinic 1.
In this study, hCG (human chorionic gonadotropin) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking hCG (human chorionic gonadotropin).